EP0811016A4 - - Google Patents

Info

Publication number
EP0811016A4
EP0811016A4 EP95914876A EP95914876A EP0811016A4 EP 0811016 A4 EP0811016 A4 EP 0811016A4 EP 95914876 A EP95914876 A EP 95914876A EP 95914876 A EP95914876 A EP 95914876A EP 0811016 A4 EP0811016 A4 EP 0811016A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95914876A
Other languages
English (en)
Other versions
EP0811016A1 (de
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0811016A1 publication Critical patent/EP0811016A1/de
Publication of EP0811016A4 publication Critical patent/EP0811016A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP95914876A 1994-03-28 1995-03-24 Auf synthetischen peptiden basierende immunogene für die behandlung der allergie Withdrawn EP0811016A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US218461 1994-03-28
US32891294A 1994-10-25 1994-10-25
PCT/US1995/003741 WO1995026365A1 (en) 1994-03-28 1995-03-24 Synthetic peptide based immunogens for the treatment of allergy
US328912 2002-12-23

Publications (2)

Publication Number Publication Date
EP0811016A1 EP0811016A1 (de) 1997-12-10
EP0811016A4 true EP0811016A4 (de) 1997-12-10

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95914876A Withdrawn EP0811016A1 (de) 1994-03-28 1995-03-24 Auf synthetischen peptiden basierende immunogene für die behandlung der allergie

Country Status (6)

Country Link
EP (1) EP0811016A1 (de)
JP (1) JPH09510975A (de)
CN (1) CN1146772A (de)
AU (1) AU2195395A (de)
CA (1) CA2186595A1 (de)
WO (1) WO1995026365A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
KR100498198B1 (ko) * 1996-03-01 2005-09-09 노파르티스 아게 알레르기에 대한 백신접종 및 치료를 위한 펩티드 임뮤노겐
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
EP1037663A2 (de) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Verfahren zur behandlung unerwünschter immunantworten
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
TR200103046T2 (tr) 1999-04-23 2002-06-21 Pharmexa A/S IL5 aktivitesini düşürmek için yöntem.
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
WO2001069253A2 (en) * 2000-03-15 2001-09-20 Heska Corporation 3d model of an fc epsilon receptor alpha chain-ige fc region complex
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
IL154219A0 (en) * 2000-09-06 2003-07-31 Pharmexa As Method for down-regulating ige
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
WO2003015716A2 (en) 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
US8697846B2 (en) * 2007-08-15 2014-04-15 Emory University Methods of making monoclonal antibodies using fusion-peptide epitope adoptive transfer (F-PEAT) technology
US8512708B2 (en) * 2008-03-13 2013-08-20 Compugen Ltd. GP96 derived peptides
DK2788021T3 (en) 2011-12-09 2017-04-10 Bavarian Nordic As POXVIRUS VECTOR FOR EXPRESSION OF BACTERIAL ANTIGENES CONNECTED TO TETANANOX INFRAGMENT C
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
JP5918851B2 (ja) * 2012-06-18 2016-05-18 日本全薬工業株式会社 ＩｇＥペプチドワクチン
EP2790442A1 (de) 2013-04-09 2014-10-15 Alcatel Lucent Steuersystem, Vorrichtung, Verfahren und computerlesbares Speichermedium zum Speichern von Anweisungen für einen Netzwerkknoten und/oder eine Netzwerksteuerung
CN112237638B (zh) * 2020-10-28 2022-11-29 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021676A1 (en) * 1993-03-24 1994-09-29 The Regents Of The University Of California IgE ISOFORMS AND METHODS OF USE
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
WO1995010532A1 (en) * 1993-10-11 1995-04-20 Peptide Therapeutics Limited Compounds useful in anti-allergy treatment
WO1996006357A1 (en) * 1994-08-24 1996-02-29 Peptide Therapeutics Limited Screen for potential therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021676A1 (en) * 1993-03-24 1994-09-29 The Regents Of The University Of California IgE ISOFORMS AND METHODS OF USE
WO1994025060A1 (en) * 1993-04-27 1994-11-10 Ladd Anna E Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
WO1995010532A1 (en) * 1993-10-11 1995-04-20 Peptide Therapeutics Limited Compounds useful in anti-allergy treatment
WO1996006357A1 (en) * 1994-08-24 1996-02-29 Peptide Therapeutics Limited Screen for potential therapeutic compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9526365A1 *

Also Published As

Publication number Publication date
WO1995026365A1 (en) 1995-10-05
AU2195395A (en) 1995-10-17
CA2186595A1 (en) 1995-10-05
EP0811016A1 (de) 1997-12-10
CN1146772A (zh) 1997-04-02
JPH09510975A (ja) 1997-11-04

Similar Documents

Publication Publication Date Title
DK0677466T3 (de)
BRPI9507160A (de)
EP0666470A3 (de)
EP0665261A3 (de)
EP0667387A3 (de)
DE69535748D1 (de)
BY1704C1 (de)
IN181606B (de)
ECSDI940187S (de)
ECSMU940033U (de)
ECSDI940213S (de)
ECSDI940203S (de)
ECSDI940182S (de)
ECSDI940194S (de)
ECSDI940191S (de)
ECSDI940190S (de)
ECSMU940035U (de)
ECSDI940184S (de)
ECSDI940183S (de)
BRPI9401073A2 (de)
IN181956B (de)
DK40195A (de)
ECSDI940180S (de)
ECSDI940181S (de)
CN3026648S (de)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961008

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19971208